|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.16 USD | +0.27% |
|
-3.27% | +5.71% |
| 02-06 | Diary - U.S. earnings week ahead | RE |
| 02-05 | Insulet Launches Omnipod® 5 and Omnipod Discover? in the Middle East to Transform Diabetes Care | CI |
| Capitalization | 27.36B 22.99B 21.01B 20.02B 37.14B 2,482B 38.61B 245B 96.78B 1,193B 103B 101B 4,270B | P/E ratio 2025 * |
33.8x | P/E ratio 2026 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise value | 27.67B 23.25B 21.25B 20.24B 37.56B 2,510B 39.05B 247B 97.87B 1,206B 104B 102B 4,318B | EV / Sales 2025 * |
5.94x | EV / Sales 2026 * | 5.2x |
| Free-Float |
95.22% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: DexCom, Inc.
| 1 day | +0.27% | ||
| 1 week | -3.27% | ||
| Current month | -3.94% | ||
| 1 month | +4.09% | ||
| 3 months | +27.56% | ||
| 6 months | -11.03% | ||
| Current year | +5.71% |
| 1 week | 67.87 |  | 72.28 |
| 1 month | 65.92 | | 75.98 |
| Current year | 65.19 | | 75.98 |
| 1 year | 54.11 | | 93.25 |
| 3 years | 54.11 | | 142 |
| 5 years | 54.11 | | 164.86 |
| 10 years | 10.66 | | 164.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 47 | 01/01/2026 |
Jereme Sylvain
DFI | Director of Finance/CFO | 46 | 19/03/2021 |
| Chief Tech/Sci/R&D Officer | 49 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 68 | 30/07/2018 |
Nick Augustinos
BRD | Director/Board Member | 67 | 20/11/2009 |
Jacob Leach
BRD | Director/Board Member | 47 | 01/01/2026 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.18% | 1.46% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.27% | -3.27% | -20.35% | -34.58% | 27.36B | |
| +0.22% | +1.52% | -13.95% | +2.78% | 193B | |
| -1.21% | -1.03% | +12.93% | +21.58% | 130B | |
| +1.12% | -0.08% | +46.55% | +134.34% | 70.67B | |
| -1.25% | +2.71% | -9.77% | -15.43% | 59.09B | |
| +2.70% | +3.48% | +47.95% | +99.75% | 59.33B | |
| +0.15% | +5.22% | - | - | 39.42B | |
| -2.68% | -7.13% | +9.93% | +27.59% | 24.07B | |
| -0.28% | -7.42% | -16.08% | -47.87% | 20.64B | |
| +1.54% | +3.00% | -24.25% | +8.34% | 19.66B | |
| Average | -0.67% | +0.56% | +3.66% | +21.83% | 64.37B | |
| Weighted average by Cap. | -0.63% | +1.12% | +5.66% | +27.71% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.66B 3.91B 3.57B 3.41B 6.32B 422B 6.57B 41.6B 16.46B 203B 17.46B 17.1B 726B | 5.23B 4.4B 4.02B 3.83B 7.1B 474B 7.38B 46.74B 18.5B 228B 19.62B 19.21B 816B |
| Net income | 831M 698M 638M 608M 1.13B 75.39B 1.17B 7.43B 2.94B 36.23B 3.12B 3.05B 130B | 989M 831M 759M 723M 1.34B 89.68B 1.4B 8.84B 3.5B 43.1B 3.71B 3.63B 154B |
| Net Debt | 310M 261M 238M 227M 421M 28.14B 438M 2.77B 1.1B 13.53B 1.16B 1.14B 48.42B | -146M -123M -112M -107M -198M -13.23B -206M -1.3B -516M -6.36B -547M -536M -22.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/02/26 | 70.16 $ | +0.27% | 4,031,502 |
| 06/02/26 | 69.97 $ | +0.11% | 3,659,937 |
| 05/02/26 | 69.89 $ | -1.31% | 5,571,968 |
| 04/02/26 | 70.82 $ | -1.13% | 7,051,273 |
| 03/02/26 | 71.63 $ | -1.24% | 5,026,743 |
Delayed Quote Nasdaq, February 10, 2026 at 01:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition